The software developer Eschbach has added AI-based search engine capabilities to its Shiftconnector digital manufacturing software for process manufacturing.  The company specializes in serving the needs of the pharmaceutical and chemical industries.  Eschbach introduced its Shiftconnector software almost two decades ago to facilitate handover, employee communication, production management and regulatory compliance. The new Smart Search functionality in the Shiftconnector…

Healiva announced today that it acquired critical manufacturing assets from B. Braun’s B. Braun Medical AG Switzerland affiliate. The companies declined to disclose financial details for the acquisition. Lugano, Switzerland-based Healiva develops precision medicine for patients with chronic and acute wounds. It acquired a qualified cell bank for the manufacturing of its first cell therapy…

Generics giant Teva Pharmaceuticals (NYSE:TEVA) has named Richard Francis, the CEO of gene therapy company Purespring Therapeutics, as its leader. Purespring Therapeutics is one of the first adeno-associated virus (AAV) gene therapy companies focused on kidney disease. Francis is also the CEO of the cardiotherapy-focused firm Forcefield Therapeutics, and an operating partner for Syncona Investment…

  GE HealthCare today announced it is investing $80 million to expand contrast media production capacity in Norway. The investment will go toward increasing manufacturing capacity by 30% at its active pharmaceutical ingredients site in Lindesnes, Norway. As a result, the investment will create around 100 new jobs. GE HealthCare officials have committed to addressing the…

The state of California is reportedly planning to work with the nonprofit generic drug company Civica Rx to produce the hormone, according to NBC. California could confirm the partnership in mid-December, but the partnership has not yet been verified. This summer, California Governor Gavin Newsom hinted that the state planned to manufacture insulin to help people with diabetes…

The biopharma Roivant Sciences (Nasdaq:ROIV) has decided to cut roughly 100 employees from its 891-person workforce. According to CEO Matt Gline, the company decided on the reorganization to allow sufficient cash runway to last until the second half of 2025. In the quarter that ended September 30, 2022, the company had a net loss of…

Eli Lilly‘s (NYSE:LLY) share price dropped about 4% Friday to $352.36 after a fake Twitter account claimed the company would make insulin available at no cost. “We are excited to announce insulin is free now,” read the fake announcement from @EliLillyandCo, which received more than 1,500 retweets and 10,000 likes before Twitter removed the bogus…

The pharma industry has been slower to adopt digital technologies than other less-regulated sectors. But many pharmaceutical companies making aggressive digital investments are beginning to see a payoff. Though comprehensive digital-based programs can cost roughly $50 million to $100 million annually for two to three years, according to McKinsey, they can lead to improved quality, increased…

Eli Lilly (NYSE:LLY) has announced that it would commercialize its Tempo personalized diabetes management platform in the U.S. before the end of 2022. The company anticipates full nationwide availability of the platform in 2023. Designed for adults with type 1 and 2 diabetes, the platform includes the Tempo Smart Button, a compatible app, and the…

Biotech Galapagos NV (Euronext & NASDAQ: GLPG) has announced a new initiative to save money while sharpening its focus on oncology and immunology. The company’s CEO, formerly the Chief Scientific Officer of Janssen (NYSE:JNJ), unveiled a new “roadmap for pipeline and commercial growth” at its R&D Day held November 4 in Mechelen, Belgium. The plan…